Regulus Therapeutics Inc (NAS:RGLS)
$ 1.54 -0.095 (-5.78%) Market Cap: 101.48 Mil Enterprise Value: 13.91 Mil PE Ratio: 0 PB Ratio: 1.03 GF Score: 41/100

Regulus Therapeutics Inc Announces Strategic Prioritization of RGLS8429 Call Transcript

Oct 12, 2021 / 09:00PM GMT
Release Date Price: $7.6 (-0.05%)
Operator

Thank you for standing by, and welcome to the Regulus Therapeutics conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your host, CEO, Jay Hagan. Sir, please go ahead.

Joseph P. Hagan
Regulus Therapeutics Inc. - President, CEO & Director

Thanks very much, and good afternoon. I'd like to thank everyone for joining us on this call, allowing us to provide the following important updates on our ADPKD program.

Before we begin, I'd like to remind you that this call will contain forward-looking statements concerning Regulus Therapeutics' future expectations, plans, prospects, corporate strategy and performance, which constitute forward-looking statements for the purposes of the safe harbor provision under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in our filings

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot